RBC Bioscience Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	23.54	21.57	6.43	3.78	28.73
Depreciation & Amortization	16.65	17.54	18.75	19.28	19.45
Other Amortization	-	0.55	0.45	0.46	0.41
Loss (Gain) From Sale of Assets	-	-0	0.02	-0.01	0.54
Asset Writedown & Restructuring Costs	-	-	-	-	0.93
Provision & Write-off of Bad Debts	0.08	0.42	0.11	-0.1	-0.37
Other Operating Activities	0.51	3.43	-7.15	1.3	-28.74
Change in Accounts Receivable	-12.8	9.09	2.48	-0.81	27.54
Change in Inventory	5.27	-8.34	2.78	4	9.59
Change in Accounts Payable	0.3	8.05	-6.99	-13.04	-65.31
Change in Unearned Revenue	0.13	0.79	0.06	-1.11	1.06
Change in Other Net Operating Assets	6.84	2.83	-3.73	-7.14	-19.11
Operating Cash Flow	40.52	55.93	13.21	6.6	-25.3
Operating Cash Flow Growth	-27.55%	323.45%	100.03%	-	-
Capital Expenditures	-6.44	-2.13	-4.99	-9.96	-449.72
Sale of Property, Plant & Equipment	-	0	-	0.01	0.01
Sale (Purchase) of Intangibles	-6.67	-8.19	-1.47	-0.09	-0.39
Investment in Securities	-1.98	-	-	-	-
Other Investing Activities	-0.34	0.95	7.47	22.65	24.44
Investing Cash Flow	-15.43	-9.37	1	12.61	-425.67
Long-Term Debt Issued	-	35	203.46	-	404.06
Total Debt Issued	-	35	203.46	-	404.06
Short-Term Debt Repaid	-25	-10	-5	-24.65	-6.35
Long-Term Debt Repaid	-39.23	-43.9	-208.89	-4.59	-8.84
Total Debt Repaid	-64.23	-53.9	-213.89	-29.24	-15.19
Net Debt Issued (Repaid)	-64.23	-18.9	-10.43	-29.24	388.87
Issuance of Common Stock	-	-	-	-	50
Common Dividends Paid	-4.28	-12.98	-14.53	-11.8	-14.38
Other Financing Activities	-	-	-	0.29	-
Financing Cash Flow	-68.52	-31.88	-24.96	-40.75	424.49
Net Cash Flow	-43.42	14.68	-10.75	-21.54	-26.48
Free Cash Flow	34.08	53.8	8.21	-3.36	-475.02
Free Cash Flow Growth	-36.64%	554.94%	-	-	-
Free Cash Flow Margin	15.51%	26.21%	4.76%	-1.93%	-189.12%
Free Cash Flow Per Share	2.37	3.75	0.57	-0.23	-35.11
Cash Interest Paid	-	10.27	10.08	7.41	5.94
Cash Income Tax Paid	-	2	8.55	0	36.35
Levered Free Cash Flow	16.8	38.36	2.95	19.92	-460.85
Unlevered Free Cash Flow	22.86	44.81	9.2	24.66	-456.89
Change in Working Capital	-0.25	12.43	-5.4	-18.11	-46.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.